373 related articles for article (PubMed ID: 30286791)
1. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
[TBL] [Abstract][Full Text] [Related]
2. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
[TBL] [Abstract][Full Text] [Related]
3. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
[TBL] [Abstract][Full Text] [Related]
4. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease.
Ping L; Kundinger SR; Duong DM; Yin L; Gearing M; Lah JJ; Levey AI; Seyfried NT
Sci Data; 2020 Sep; 7(1):315. PubMed ID: 32985496
[TBL] [Abstract][Full Text] [Related]
5. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease.
Higginbotham L; Dammer EB; Duong DM; Modeste E; Montine TJ; Lah JJ; Levey AI; Seyfried NT
Proteomes; 2019 Aug; 7(3):. PubMed ID: 31461916
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
Modeste ES; Ping L; Watson CM; Duong DM; Dammer EB; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2023 Jul; 18(1):48. PubMed ID: 37468915
[TBL] [Abstract][Full Text] [Related]
7. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
[TBL] [Abstract][Full Text] [Related]
8. Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease.
Hurst C; Pugh DA; Abreha MH; Duong DM; Dammer EB; Bennett DA; Herskowitz JH; Seyfried NT
Mol Cell Proteomics; 2023 May; 22(5):100542. PubMed ID: 37024090
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
Chen M; Xia W
J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
[TBL] [Abstract][Full Text] [Related]
11. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
[TBL] [Abstract][Full Text] [Related]
12. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T; Glass J; Gearing M; Thambisetty M; Troncoso JC; Geschwind DH; Lah JJ; Levey AI
Cell Syst; 2017 Jan; 4(1):60-72.e4. PubMed ID: 27989508
[TBL] [Abstract][Full Text] [Related]
13. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.
Rayaprolu S; Gao T; Xiao H; Ramesha S; Weinstock LD; Shah J; Duong DM; Dammer EB; Webster JA; Lah JJ; Wood LB; Betarbet R; Levey AI; Seyfried NT; Rangaraju S
Mol Neurodegener; 2020 May; 15(1):28. PubMed ID: 32381088
[TBL] [Abstract][Full Text] [Related]
14. Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer's Disease.
Yu K; Niu M; Wang H; Li Y; Wu Z; Zhang B; Haroutunian V; Peng J
J Am Soc Mass Spectrom; 2021 Apr; 32(4):936-945. PubMed ID: 33683887
[TBL] [Abstract][Full Text] [Related]
15. Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
Johnson ECB; Carter EK; Dammer EB; Duong DM; Gerasimov ES; Liu Y; Liu J; Betarbet R; Ping L; Yin L; Serrano GE; Beach TG; Peng J; De Jager PL; Haroutunian V; Zhang B; Gaiteri C; Bennett DA; Gearing M; Wingo TS; Wingo AP; Lah JJ; Levey AI; Seyfried NT
Nat Neurosci; 2022 Feb; 25(2):213-225. PubMed ID: 35115731
[TBL] [Abstract][Full Text] [Related]
16. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
[TBL] [Abstract][Full Text] [Related]
17. A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy.
Gutierrez-Quiceno L; Dammer EB; Johnson AG; Webster JA; Shah R; Duong D; Yin L; Seyfried NT; Alvarez VE; Stein TD; McKee AC; Hales CM
Mol Neurodegener; 2021 Jun; 16(1):40. PubMed ID: 34172091
[TBL] [Abstract][Full Text] [Related]
18. Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
Guo Q; Dammer EB; Zhou M; Kundinger SR; Gearing M; Lah JJ; Levey AI; Shulman JM; Seyfried NT
Front Mol Neurosci; 2021; 14():623659. PubMed ID: 33815056
[TBL] [Abstract][Full Text] [Related]
19. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
Bai B; Hales CM; Chen PC; Gozal Y; Dammer EB; Fritz JJ; Wang X; Xia Q; Duong DM; Street C; Cantero G; Cheng D; Jones DR; Wu Z; Li Y; Diner I; Heilman CJ; Rees HD; Wu H; Lin L; Szulwach KE; Gearing M; Mufson EJ; Bennett DA; Montine TJ; Seyfried NT; Wingo TS; Sun YE; Jin P; Hanfelt J; Willcock DM; Levey A; Lah JJ; Peng J
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16562-7. PubMed ID: 24023061
[TBL] [Abstract][Full Text] [Related]
20. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C;
Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
